Arthritis & Rheumatism

Modifiable risk factors contribute to gout

Elevated urate in the blood (hyperuricemia) is a precursor of gout, which is the most common form of inflammatory arthritis worldwide. A study published in Arthritis & Rheumatology that included 14,624 U.S. adults found that ...

Diseases, Conditions, Syndromes

Many patients with gout do not receive recommended treatment

Among patients in England with gout, only a minority of those with indications to receive urate-lowering therapy were treated according to guideline recommendations, according to a study in the December 24/31 issue of JAMA.

Arthritis & Rheumatism

Exposure to inorganic dust increases risk of gout in women by 27%

The results of a study presented today at the Annual European Congress of Rheumatology (EULAR 2019) demonstrate that occupational exposure to inorganic dust is a previously unknown risk factor for gout and also confirm known ...

Arthritis & Rheumatism

Febuxostat prevents gout flares in recent clinical trial

As reported in the journal Arthritis & Rheumatology, the drug febuxostat reduced gout flares in a double-blind, placebo-controlled study of 314 adults with early gout. Febuxostat treatment also reduced synovitis—or inflammation ...

Oncology & Cancer

Allopurinol Rx more likely with eligibility at diagnosis

(HealthDay)—Allopurinol prescribing is more likely if patients meet eligibility criteria at diagnosis, according to a research brief published in the November/December issue of the Annals of Family Medicine.

page 10 from 12